
Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Composition: Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG
Form: Pharmaceutical Tablet / Capsule
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG Brand Options

Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG — PCD Franchise & Distributorship
Pack: Available in 1 x 10 tablets and bulk options
View Details →Moxiphar-CV Suspension– Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG
Brand: Biophar® Brand Name: Moxiphar-CV 1G Suspension Generic Name: Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG Dosage Form: Suspension Packing: 2.5gx10ml Category: AntibioticsProduct Overview
✅Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG (Moxiphar, CV Suspension), Pharma Franchise & Third Party Manufacturing
Biophar Lifesciences offers you Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG (Moxiphar, CV Suspension), a very well-known and trusted antibiotic formulation that is most commonly prescribed for bacterial infections in paediatric patients. This combination medicine is characterised by its broad-spectrum antibacterial action, and it is quite consistently recommended by healthcare professionals for the treatment of paediatric respiratory, urinary, skin, and soft tissue infections.If you want to have a pharma franchise for Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG and also PCD Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG, then Biophar Lifesciences is the best place to consider for great business opportunities, along with top-notch manufacturing standards and profitable margins.Product Overview
Product Name: Moxiphar CV Suspension Composition: Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG Dosage Form: Oral Suspension Category: Paediatric AntibioticAmoxicillin is a bactericidal antibiotic that kills bacteria by preventing them from forming a cell wall. While potassium clavulanate resists bacteria by keeping amoxicillin active against bacteria that produce the beta-lactamase enzyme, a major way in which bacteria become resistant to antibiotics. This combination makes the formulation highly effective against a wide range of bacterial infections.✅Benefits of Moxiphar CV Suspension
Generally, Moxiphar CV Suspension is given to children experiencing ear infections, throat infections, bronchitis, sinusitis, urinary tract infections, and skin infections. The suspension version facilitates easy dosage and increased willingness of children to take the medicine.It is made by following very strict quality control procedures, which comply with IP standards. Besides, to assure safety, purity, and effectiveness, it is done in WHO- and GMP-certified facilities.Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG
Biophar Lifesciences, through its Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG programme, offers a profitable avenue for distributors and medical representatives. Our franchise system is structured to provide our partners with exclusive rights, promotional support, and an uninterrupted supply of products.The major benefits are:- Highly demanded paediatric antibiotic
- Attractive promotional inputs
- Competitive pricing
- On-time product delivery
- Strong brand support
✅PCD Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG
The PCD Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG we offer is a great opportunity for individuals and entities wanting to establish themselves in the paediatric sector. As bacterial infection cases keep on increasing, this combination suspension is highly preferred and prescribed from time to time.Biophar Lifesciences offers marketing materials, sales aids, and business support to its franchise partners for them to be successful even in the most competitive markets.Third-Party Manufacturing of Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG
Besides the franchise opportunities, we also have third-party manufacturing of Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG at your disposal. Our manufacturing unit, equipped with the latest technology, strictly follows quality assurance procedures and all the safety guidelines of the industry.We provide:- Customised packaging solutions
- Bulk manufacturing capabilities
- Private labelling options
- Manufacturing competitive rates
- Production and dispatch on time



